Amarin Corp Plc (AMRN)

[shadolane]

The FDA should not compromise on this topic. People believe they are getting equivalency and are not.

This is not unique to pharma either. Critical components that are of inferior material and/or processing could result in the wings falling off a plane. Maybe the FDA should think in those terms when they consider being liberal with equivalency.